dg-gt Sign Up Information

Dear William,

We are happy to let you know that you can now register for our upcoming Gene Therapy Symposium 'Making Gene Therapy a Clinical Reality'!

The Symposium is organised in collaboration with the Volkswagen Foundation. 

The Symposium will take place in Hannover, Germany, 16-18 March in the stunning Herrenhausen Palace. We welcome abstract submissions; the deadline for both early bird registrations and abstract submissions is 10 February.

As always we offer reduced rates for DG-GT members; you can check your membership status once logged into your DG-GT account. If you run into any issues or need support applying for or renewing your membership, please let us know.

We have put together an exciting series of topics with expert speakers from Germany, Europe, and the United States; please see the programme and all other relevant meeting information here. 

We look forward to welcoming you to Hannover; please spread the word amongst your colleagues and friends!

Warm regards

The DG-GT Team

Dear William,

We are happy to let you know that you can now register for our upcoming Gene Therapy Symposium 'Making Gene Therapy a Clinical Reality'!

The Symposium is organised in collaboration with the Volkswagen Foundation. 

The Symposium will take place in Hannover, Germany, 16-18 March in the stunning Herrenhausen Palace. We welcome abstract submissions; the deadline for both early bird registrations and abstract submissions is 10 February.

As always we offer reduced rates for DG-GT members; you can check your membership status once logged into your DG-GT account. If you run into any issues or need support applying for or renewing your membership, please let us know.

We have put together an exciting series of topics with expert speakers from Germany, Europe, and the United States; please see the programme and all other relevant meeting information here. 

We look forward to welcoming you to Hannover; please spread the word amongst your colleagues and friends!

Warm regards

The DG-GT Team

Dear William

Abstract submission is now over for our upcoming Gene Therapy Symposium 'Making Gene Therapy a Clinical Reality but there are still a few days left to register for the meeting.

Please also note that this year we have a hard registration deadline on 21 FEBRUARY as we have to give final delegate numbers to the venue by then.

The Symposium, organised in collaboration with the Volkswagen Foundation will take place in Hannover, Germany, 16-18 March at the stunning Herrenhausen Palace. 

As always we offer reduced rates for DG-GT members; you can check your membership status once logged into your DG-GT account. If you run into any issues or need support applying for or renewing your membership, please let us know.

We have put together an exciting series of topics with expert speakers from Germany, Europe (including the UK), the United States and even Australia; please see the programme and all other relevant meeting information here. 

We look forward to welcoming you to Hannover; please spread the word amongst your colleagues and friends!

Warm regards

The DG-GT Team

Dear William

Abstract submission is now over for our upcoming Gene Therapy Symposium 'Making Gene Therapy a Clinical Reality but there are still a few days left to register for the meeting.

Please also note that this year we have a hard registration deadline on 21 FEBRUARY as we have to give final delegate numbers to the venue by then.

The Symposium, organised in collaboration with the Volkswagen Foundation will take place in Hannover, Germany, 16-18 March at the stunning Herrenhausen Palace. 

As always we offer reduced rates for DG-GT members; you can check your membership status once logged into your DG-GT account. If you run into any issues or need support applying for or renewing your membership, please let us know.

We have put together an exciting series of topics with expert speakers from Germany, Europe (including the UK), the United States and even Australia; please see the programme and all other relevant meeting information here. 

We look forward to welcoming you to Hannover; please spread the word amongst your colleagues and friends!

Warm regards

The DG-GT Team

Dear William,


Don't forget to join us live on YouTube tomorrow 27 May from 14:00 CEST for our e-School. 

This will be the third talk of part 1: Viral and non-viral vectors for gene therapy and gene editing

Len Seymour
Oxford University

Adenoviral vectors – gene delivery tool, powerful weapon in cancer and beyond

Chair: Hildegard Büning, Hannover Medical
School 


Followed by the first talk of the e-Seminar series: SARS CoV2 tomorrow 27 May at 15:00 CEST

Dong-Yan JIN
The University of Hong Kong

Current insights on the origin of SARS-CoV2

Chair: Hildegard Büning, Hannover Medical
School 


You don't need to have a YouTube account to watch the live session but you will need to log in to be able to ask questions.  It is possible to log into YouTube using your google account and if you do not have one you can email your questions to office@esgct.eu. 

This presentation will be recorded and available to view on YouTube for the coming weeks.

If you have any questions please do not hesitate to contact us at office@esgct.eu

Kind regards,

Gaëlle 

for the DGGT Team

Dear William,

Don't forget to join us live on YouTube tomorrow 24 June from 14:00 CEST for our e-School. 

This will be the last talk of part 1: Viral and non-viral vectors for gene therapy and gene editing

Urs Greber
University of Zurich

Learn from viruses to improve viral and non-viral vectors



Chair: Hildegard Büning, Hannover Medical School

You don't need to have a YouTube account to watch the live session but you will need to log in to be able to ask questions.  It is possible to log into YouTube using your google account and if you do not have one you can email your questions to office@esgct.eu. 

These presentations will be recorded and available to view on YouTube for the coming weeks.

Kind regards,

Gaëlle 

for the DGGT Team

Dear William,

 
The DGGT board is happy to announce the winner of the
 
Else Kröner Fresenius Prize for Medical Research 2020 Genome Editing and Gene Therapy



Alessandro Aiuti MD, PhD
San Raffaele Telethon Institute for Gene Therapy
IRCCS Ospedale San Raffaele and Vita Salute San Raffaele University, Milan
 
is awarded with 2.5 million euros for his groundbreaking contributions to the advancement of therapies for immunodeficiencies and other genetic diseases.
 
Please watch the video spot on our website: www.ekfs.de/en/medprize2020
 
The DGGT board would like to extend their warmest congratulations to Alessandro for this fantastic achievement.


Warm regards

for the DGGT Team

Dear William,


Don't forget to join HIldegard Büning live on YouTube tomorrow 3 June from 14:00 CEST for the ESGCT e-School. 

This will be the fourth talk of part 1: Viral and non-viral vectors for gene therapy and gene editing

Hildegard Büning
Hannover Medical School 

Adeno-associated virus (AAV) vectors – to teach an old virus new tricks


Chair: Juan Bueren, CIEMAT, Madrid
 

Followed by the second talk of the e-Seminar series: SARS CoV2 tomorrow 3 June at 15:00 CEST


Daniel Lucey
O’Neill Institute for National and Global Health Law, Washington DC

The Covid-19 pandemic

Chair: Hildegard Büning, Hannover Medical
School 


You don't need to have a YouTube account to watch the live session but you will need to log in to be able to ask questions.  It is possible to log into YouTube using your google account and if you do not have one you can email your questions to office@esgct.eu. 

This presentation will be recorded and available to view on YouTube for the coming weeks.

Kind regards,

Gaëlle 

for the DGGT Team

Dear William,

 
The DGGT board is happy to announce the winner of the
 
Else Kröner Fresenius Prize for Medical Research 2020 Genome Editing and Gene Therapy



Alessandro Aiuti MD, PhD
San Raffaele Telethon Institute for Gene Therapy
IRCCS Ospedale San Raffaele and Vita Salute San Raffaele University, Milan
 
is awarded with 2.5 million euros for his groundbreaking contributions to the advancement of therapies for immunodeficiencies and other genetic diseases.
 
Please watch the video spot on our website: www.ekfs.de/en/medprize2020
 
The DGGT board would like to extend their warmest congratulations to Alessandro for this fantastic achievement.


Warm regards

for the DGGT Team

Dear William,


Don't forget to join us live on YouTube tomorrow 27 May from 14:00 CEST for our e-School. 

This will be the third talk of part 1: Viral and non-viral vectors for gene therapy and gene editing

Len Seymour
Oxford University

Adenoviral vectors – gene delivery tool, powerful weapon in cancer and beyond

Chair: Hildegard Büning, Hannover Medical
School 


Followed by the first talk of the e-Seminar series: SARS CoV2 tomorrow 27 May at 15:00 CEST

Dong-Yan JIN
The University of Hong Kong

Current insights on the origin of SARS-CoV2

Chair: Hildegard Büning, Hannover Medical
School 


You don't need to have a YouTube account to watch the live session but you will need to log in to be able to ask questions.  It is possible to log into YouTube using your google account and if you do not have one you can email your questions to office@esgct.eu. 

This presentation will be recorded and available to view on YouTube for the coming weeks.

If you have any questions please do not hesitate to contact us at office@esgct.eu

Kind regards,

Gaëlle 

for the DGGT Team

Dear William

As you will now be aware, some of DG-GT's activities have been affected by the COVID-19 pandemic. Further details are provided below, and we will continue to update you on the status of these activities as and when we have more information. Any changes or updates will be communicated as soon as possible via our website, mailing list and social media. We appreciate your patience and understanding during this uncertain time.

As a society, we wish to extend our thoughts and very best wishes to all of our members, supporters and community, including many who are re-focussing their efforts to contribute to the fight against COVID-19. We look forward to seeing you all at our events in the near future.

Kind regards,

Gaëlle Jamar
on behalf of the DG-GT Board
 

EVENTS

Annual Meeting Status Update

We are hoping to postpone the DG-GT Symposium to the beginning of 2021 and we are very keen to have it at the Herrenhausen Palace in Hannover in the exact same format. We are currently liaising with the Volkswagen Foundation to confirm venue availability and to make alternative arrangements. We will of course keep you informed.

NEWS

DG-GT Outreach Programme

As announced a couple of weeks ago the DG-GT is launching an outreach programme, to support members who are organising outreach activities. Check our website for more details on this programme.
 

ESGCT Webinars

The ESGCT will be organising a series of educational and COVID-19 webinars with talks similar to those scheduled to take place at the ESGCT Spring School. More on this to follow next week or keep checking the website for a detailed schedule.
 

ASGCT 2020 Annual Meeting

ASGCT 2020 has gone virtual. If you are not yet registered, this might be your chance to take part to the ASGCT congress. With lower registration rates and no travel or accommodation costs, the ASGCT is promising to offer a complete congress with exhibition hall, numerous sessions and outstanding speakers. REGISTER AND VIEW PROGRAMME.

COVID-19 Information

• Human Gene Therapy: Our journal, Human Gene Therapy, now has a Coronavirus web page dedicated to the virus research including some very interesting articles. VIEW HERE.
• Vaccine Clinical Trial: Our long term sponsor BioNTech has partnered with Pfizer to announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates. See more information in their press release.
   

Who's Who in Gene & Cell Therapy

Our Sponsors

We would like to thank all the sponsors who are supporting our society.

Dear William

As you will now be aware, some of DG-GT's activities have been affected by the COVID-19 pandemic. Further details are provided below, and we will continue to update you on the status of these activities as and when we have more information. Any changes or updates will be communicated as soon as possible via our website, mailing list and social media. We appreciate your patience and understanding during this uncertain time.

As a society, we wish to extend our thoughts and very best wishes to all of our members, supporters and community, including many who are re-focussing their efforts to contribute to the fight against COVID-19. We look forward to seeing you all at our events in the near future.

Kind regards,

Gaëlle Jamar
on behalf of the DG-GT Board
 

EVENTS

Annual Meeting Status Update

We are hoping to postpone the DG-GT Symposium to the beginning of 2021 and we are very keen to have it at the Herrenhausen Palace in Hannover in the exact same format. We are currently liaising with the Volkswagen Foundation to confirm venue availability and to make alternative arrangements. We will of course keep you informed.

NEWS

DG-GT Outreach Programme

As announced a couple of weeks ago the DG-GT is launching an outreach programme, to support members who are organising outreach activities. Check our website for more details on this programme.
 

ESGCT Webinars

The ESGCT will be organising a series of educational and COVID-19 webinars with talks similar to those scheduled to take place at the ESGCT Spring School. More on this to follow next week or keep checking the website for a detailed schedule.
 

ASGCT 2020 Annual Meeting

ASGCT 2020 has gone virtual. If you are not yet registered, this might be your chance to take part to the ASGCT congress. With lower registration rates and no travel or accommodation costs, the ASGCT is promising to offer a complete congress with exhibition hall, numerous sessions and outstanding speakers. REGISTER AND VIEW PROGRAMME.

COVID-19 Information

• Human Gene Therapy: Our journal, Human Gene Therapy, now has a Coronavirus web page dedicated to the virus research including some very interesting articles. VIEW HERE.
• Vaccine Clinical Trial: Our long term sponsor BioNTech has partnered with Pfizer to announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates. See more information in their press release.
   

Who's Who in Gene & Cell Therapy

Our Sponsors

We would like to thank all the sponsors who are supporting our society.